First Time Loading...
C

Chalkis Health Industry Co Ltd
SZSE:000972

Watchlist Manager
Chalkis Health Industry Co Ltd
SZSE:000972
Watchlist
Price: 3.05 CNY -0.33% Market Closed
Updated: May 21, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

1.2B
-14%
Assets
Growth Rates:
1 Year
+48%
3 Years
+110%
5 Years
0%
7 Years
-49%
10 Years
-55%
1B
-21%
Liabilities
Growth Rates:
1 Year
+40%
3 Years
+151%
5 Years
+29%
7 Years
-35%
10 Years
-62%
203.5m
+47%
Equity
Growth Rates:
1 Year
+114%
3 Years
+16%
5 Years
-54%
7 Years
-76%
10 Years
+344%

Balance Sheet Decomposition
Chalkis Health Industry Co Ltd

1.2B
Assets
1B
Liabilities
1.2B
Assets
1B
Liabilities
Current Assets 781.9m
Cash & Short-Term Investments 98.9m
Receivables 50.2m
Other Current Assets 632.8m
Non-Current Assets 442.2m
Long-Term Investments 3.9m
PP&E 421.7m
Intangibles 15.7m
Other Non-Current Assets 899.5k
Current Liabilities 925.2m
Accounts Payable 104.1m
Accrued Liabilities 78.4m
Short-Term Debt 588.1m
Other Current Liabilities 154.6m
Non-Current Liabilities 95.3m
Long-Term Debt 72.5m
Other Non-Current Liabilities 22.8m

Balance Sheet
Chalkis Health Industry Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
127
335
223
124
57
81
37
20
176
99
Cash
0
0
0
0
0
0
0
20
176
99
Cash Equivalents
127
335
223
124
57
81
37
0
0
0
Total Receivables
300
251
300
236
249
229
183
175
99
50
Accounts Receivables
111
152
183
136
168
159
143
136
89
33
Other Receivables
189
100
117
100
81
69
41
39
11
18
Inventory
419
587
641
902
243
26
0
161
217
616
Other Current Assets
16
111
16
13
71
1
1
3
44
16
Total Current Assets
862
1 284
1 180
1 275
619
336
221
359
536
782
PP&E Net
827
978
851
826
502
400
354
315
287
422
PP&E Gross
827
978
851
826
502
400
354
315
287
422
Accumulated Depreciation
588
739
857
1 038
791
757
804
848
889
903
Intangible Assets
13
102
97
93
85
2
2
2
2
16
Goodwill
0
0
0
0
0
0
0
0
0
0
Note Receivable
6
5
0
0
0
0
0
0
0
0
Long-Term Investments
263
260
283
151
20
0
0
0
0
4
Other Long-Term Assets
1
1
2
2
1
2
5
0
1
1
Other Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
1 971
N/A
2 630
+33%
2 413
-8%
2 347
-3%
1 227
-48%
740
-40%
583
-21%
676
+16%
825
+22%
1 224
+48%
Liabilities
Accounts Payable
517
720
599
328
61
28
33
40
88
104
Accrued Liabilities
56
18
28
34
46
35
40
48
72
78
Short-Term Debt
306
341
384
346
198
177
130
319
332
588
Current Portion of Long-Term Debt
0
30
0
0
0
0
0
18
0
8
Other Current Liabilities
310
426
595
740
465
49
44
43
105
147
Total Current Liabilities
1 077
1 536
1 605
1 448
770
288
246
468
597
925
Long-Term Debt
63
0
0
0
0
0
20
0
0
73
Deferred Income Tax
0
0
1
8
0
0
0
0
0
0
Minority Interest
59
57
72
3
4
6
5
5
5
6
Other Liabilities
64
64
46
11
14
4
136
133
128
17
Total Liabilities
1 144
N/A
1 542
+35%
1 581
+2%
1 469
-7%
788
-46%
298
-62%
407
+36%
607
+49%
730
+20%
1 021
+40%
Equity
Common Stock
771
771
771
771
771
771
771
771
771
771
Retained Earnings
698
760
1 014
982
1 406
1 350
1 616
1 723
1 697
1 588
Additional Paid In Capital
750
1 073
1 073
1 073
1 073
1 072
1 072
1 072
1 072
1 072
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
51
Other Equity
4
3
2
16
0
51
51
51
51
0
Total Equity
827
N/A
1 087
+32%
832
-24%
878
+6%
439
-50%
442
+1%
176
-60%
69
-61%
95
+38%
204
+114%
Total Liabilities & Equity
1 971
N/A
2 630
+33%
2 413
-8%
2 347
-3%
1 227
-48%
740
-40%
583
-21%
676
+16%
825
+22%
1 224
+48%
Shares Outstanding
Common Shares Outstanding
771
771
771
771
771
771
771
771
771
771

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.